Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03448601 · ClinicalTrials.gov registry record · NA
Alzheimer's Disease and Precision Medicine Research Among Native People
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 523
- Enrollment target
NCT03448601: Completed NA study, sponsored by University of Colorado, Denver.
NCT03448601 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 523 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03448601, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 523 participants
- Enrollment target
Study Summary
This project intends to address the gaps in Alzheimer's disease (AD) and precision medicine (PM) research in American Indian and Alaska Native (AI/AN) populations by comparing written and video-based materials for recruitment into AD and PM research, and by creating an AD-PM registry of AI/AN individuals who are willing to be contacted for future research opportunities.
Primary Outcome
Completion of the AD-PM Module will be assessed by binary (yes, no) indicators of 1) providing consent for the Module; and 2) answering a question about enrolling in the AD-PM cohort and by a variable summarizing the total number of missing responses for the AD-PM module questions.
Interventions
- OTHER Culturally tailored brochure intervention group
- OTHER Culturally tailored video intervention group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 523 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
What the finished NCT03448601 record still lists
NCT03448601 is an interventional study that assigns participants to a tested intervention. The registered 523 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 2 interventions - of which Culturally tailored brochure intervention group is the first listed.
NCT03448601 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03448601 about?
NCT03448601 is a clinical study titled "Alzheimer's Disease and Precision Medicine Research Among Native People". This project intends to address the gaps in Alzheimer's disease (AD) and precision medicine (PM) research in American Indian and Alaska Native (AI/AN) populations by comparing written and video-based materials for recruitment into AD and PM research, and by creating an AD-PM registry of AI/AN indivi...
What is the current status of trial NCT03448601?
This trial is currently completed. It is a NA study. The enrollment target is 523 participants. The study started on 2021-05-01. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT03448601?
The interventions under investigation include: Culturally tailored brochure intervention group (OTHER), Culturally tailored video intervention group (OTHER).
Who is sponsoring clinical trial NCT03448601?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03448601's enrollment target sits among peer trials
523 189th of 2000 higher than 1,812 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03526835 · 523 participants · Phase 1
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- NCT04580134 · 524 participants · Phase 4
CLOZAPINE Response in Biotype-1
- NCT07158814 · 524 participants · Phase 4
Safety of RSV Preventive Monoclonal Antibody
- NCT06835686 · 522 participants · NA
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI